Tsutomu Oikawa
- Molecular Biology top 10%
- Cancer Research top 5%
- Pharmacology top 5%
- Oncology top 10%
- Nutrition and Dietetics top 5%
- Co-authors
- Mariko ShimamuraTakao IwaguchiKenji HirotaniOsamu NakamuraAkiyoshi HiragunHiromi AshinoYasuhiro IgarashiIkuo Morita
- Topics
- Angiogenesis and VEGF in Cancer (22 papers)Microbial Natural Products and Biosynthesis (13 papers)Marine Sponges and Natural Products (11 papers)
- Journals
- Biochemical and Biophysical Research CommunicationsBritish Journal of CancerInternational Journal of Cancer
- Partner nations
- JapanThailandUnited States
In The Last Decade
Tsutomu Oikawa
70 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 107
- Molecular Biology 1.0k
- Cancer Research 311
- Pharmacology 259
- Oncology 259
- Nutrition and Dietetics 207
Countries citing papers authored by Tsutomu Oikawa
This map shows the geographic impact of Tsutomu Oikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsutomu Oikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsutomu Oikawa more than expected).
Fields of papers citing papers by Tsutomu Oikawa
This network shows the impact of papers produced by Tsutomu Oikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsutomu Oikawa. The network helps show where Tsutomu Oikawa may publish in the future.
Co-authorship network of co-authors of Tsutomu Oikawa
This figure shows the co-authorship network connecting the top 25 collaborators of Tsutomu Oikawa. A scholar is included among the top collaborators of Tsutomu Oikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsutomu Oikawa. Tsutomu Oikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Nobiletin, a citrus polymethoxyflavonoid, suppresses multiple angiogenesis-related endothelial cell functions and angiogenesis in vivo | 1 |
| 2 | 46 | |
| 3 | 74 | |
| 4 | 125 | |
| 5 | 6 | |
| 6 | 111 | |
| 7 | Effects of cytogenin, a novel microbial product, on embryonic and tumor cell-induced angiogenic responses in vivo. | 66 |
| 8 | 14 | |
| 9 | Influence of Nitrogen Application on the Contents of Glutelin and Prolamin of Polished Rice Grains (Oryza sativa L.) | 5 |
| 10 | 33 | |
| 11 | 5 | |
| 12 | 7 | |
| 13 | 11 | |
| 14 | 44 | |
| 15 | Phylogenetic relationships among laboratory animals deduced from basement membrane type IV collagen antigens | 0 |
| 16 | 44 | |
| 17 | 23 | |
| 18 | 37 | |
| 19 | The diagnosis of nitrogen nutrition of rice plants (Sasanishiki) using chlorophyll-meter. | 27 |
| 20 | 1 |
About Tsutomu Oikawa
Tsutomu Oikawa is a scholar working on Biotechnology, Pharmacology and Immunology and Allergy, having authored 73 papers that have together received 1.8k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (22 papers), Microbial Natural Products and Biosynthesis (13 papers) and Marine Sponges and Natural Products (11 papers). The work is most often cited by research in Biotechnology (193 citations), Biochemistry (131 citations) and Cancer Research (311 citations). Tsutomu Oikawa has collaborated with scholars based in Japan, Thailand and United States. Frequent co-authors include Mariko Shimamura, Takao Iwaguchi, Kenji Hirotani, Osamu Nakamura, Akiyoshi Hiragun, Hiromi Ashino, Yasuhiro Igarashi, Ikuo Morita, Koichi Shudo and Megumi Ikeda. Their work appears in journals such as Biochemical and Biophysical Research Communications, British Journal of Cancer and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.